Related Experiment Video

Updated: May 10, 2026

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

Fertility preservation in the male with cancer

Daniel H Williams1

  • 1Department of Urology, University of Wisconsin School of Medicine and Public Health, 1685 Highland Avenue, Madison, WI 53705-2281, USA. williams@urology.wisc.edu

Insights

Sperm cryopreservation before cancer treatment offers men the best chance for biological fatherhood. Improved education and coordinated strategies are vital for prioritizing fertility preservation in male cancer patients.

Area of Science:

  • Oncology
  • Reproductive Medicine
  • Men's Health

Background:

  • Cancer therapies like chemotherapy and radiation can severely impair male reproductive potential.
  • Malignancy itself can negatively impact sperm production (spermatogenesis).
  • Fertility preservation is crucial for male cancer patients desiring biological children.

Purpose of the Study:

  • To review current concepts, recommendations, and principles of fertility preservation in men with cancer.
  • To address obstacles and future directions for sperm banking and fertility-preserving technologies.
  • To emphasize the importance of offering sperm cryopreservation before cancer treatment.

Main Methods:

  • Literature review of current concepts and recommendations.
  • Discussion of obstacles to sperm banking.
  • Exploration of future fertility-preserving technologies.

Main Results:

  • Sperm cryopreservation prior to cancer treatment is the most effective option for maintaining reproductive potential.
  • All cancer treatments pose risks to male fertility.
  • Cancer diagnosis can also directly affect sperm production.

Conclusions:

  • Sperm cryopreservation should be offered to all men with cancer before treatment initiation.
  • Enhanced patient and provider education is necessary.
  • Coordinated strategies within cancer care centers are essential to prioritize fertility preservation.

Related Concept Videos

Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...